Cell-cell junctions are an integral part of epithelia and are often disrupted in cancer cells during epithelial-to-mesenchymal transition (EMT), which is a main driver of metastatic spread. We show here that Metastasis suppressor-1 (Mtss1; Missing in Metastasis, MIM), a member of the IMD-family of proteins, inhibits cell-cell junction disassembly in wound healing or HGFinduced scatter assays by enhancing cell-cell junction strength. Mtss1 not only makes cells more resistant to cell-cell junction disassembly, but also accelerates the kinetics of adherens junction assembly. Mtss1 drives enhanced junction formation specifically by elevating Rac-GTP. Lastly, we show that Mtss1 depletion reduces recruitment of F-actin at cell-cell junctions. We thus propose that Mtss1 promotes Rac1 activation and actin recruitment driving junction maintenance. We suggest that the observed loss of Mtss1 in cancers may compromise junction stability and thus promote EMT and metastasis.
Introduction
E-cadherin is the major epithelial cadherin and it is frequently lost during epithelial to mesenchymal transition (EMT [1] ) and cancer metastasis. Cadherins link adherens junctions to the actin cytoskeleton [2] . The small GTPase Rac1 is a key regulator of the epithelial actin cytoskeleton, which influences dynamics of cell-cell contacts [3, 4, 5, 6, 7] . Rac1 is activated upon E-cadherin clustering during de novo cell junction formation and activity decreases as junctions mature [4, 7, 8] . Activation of Rac1 inhibits the constitutive endocytosis of E-cadherin via recruitment of IQ-GAP-1 and F-actin to cell-cell junctions [9, 10] .
Metastasis suppressor-1 (Mtss1) is a member of the IMD-family (IRSp53 and MIM domain) [11] . Mtss1 is expressed in early phases of tumorigenesis but is lost in metastatic cells and is thus a putative metastatic suppressor thought to inhibit cell motility [12, 13, 14, 15, 16] . Mtss1 is required for maintenance of intracellular junctional integrity in the mouse kidney and co-localizes with E-cadherin in MDCK cells where it promotes F-actin assembly [17] . Mtss1 is also required for border cell migration in Drosophila oocytes [18] , which migrate between adjacent nurse cells using Drosophila E-cadherin [19] . Mtss1 induces Rac1, but not Cdc42, activation via the IMD but not directly as a Rac1-GEF [20, 21, 22, 23] .
Results and Discussion

Mtss1 inhibits HGF-induced cell scattering
We used HGF-induced scattering of head and neck squamous carcinoma cells (HNSCC) as a simple model for EMT to probe a role for Mtss1 as a metastatic suppressor. Stable Mtss1-GFP overexpression in Scc9 cells reduced HGF-induced scattering ( Figure 1A and B; Movie S1). We also tested an inactivating four-lysine mutation of the IMD, K4D, defective in Rac and lipid binding [20] . Although we could only achieve a relatively low expression, the K4D construct only weakly inhibited HGFinduced scattering ( Figure 1A and B).
HGF-induced scattering requires the breakdown of cell-cell junctions so we analyzed the localization of E-cadherin in cell colonies undergoing HGF scattering ( Figure 1C ). HGF treatment of Scc9 colonies reduced the number of E-cadherin cell-cell contacts by approximately half ( Figure 1D ). Mtss1-GFP expressing colonies were more resistant to HGF and still retained the majority of their E-cadherin junctions after 6 h ( Figure 1C, D) . K4D mutant expressing unstimulated colonies possessed significantly fewer cellcell contacts compared to control cells, which underwent further disassembly in response to HGF ( Figure 1C, D) . Therefore the K4D mutant may be acting as a dominant negative construct that results in cell junction disassembly. It was curious that although K4D reduced the number of cell-cell contacts, it did not enhance scattering ( Figure 1A ) in response to HGF. This may be because expression of the K4D mutant has a slightly detrimental effect on cells overall (they grew somewhat more slowly and we were unable to express K4D to high levels, unpublished observations).
Stable cell-cell contacts contain an immobile fraction of Ecadherin, which impairs tumor cell movement (Serrels et al., 2009). We therefore hypothesized that the strengthening of cellcell contacts by Mtss1 might lead to slower migration. Normal Scc9 cells closed scratch wounds by 20 h ( Figure S1A ,B Movie S2) while Mtss1-GFP expressing showed only a 15-20% decrease wound area by 20 h ( Figure S1B ). Furthermore, Mtss1-GFP expressing Scc9 cells still retained strong localization of E-cadherin to cell junctions ( Figure S1C-E) , consistent with the possibility that Mtss1 strengthens cell-cell contacts and therefore slows motility.
We also examined single cell behavior, as Mtss1 has been proposed to negatively regulate fibroblast motility [24] . Under conditions where cell-cell junctions were disassembled in confluent monolayers by overnight incubation in calcium-free medium, Mtss1-GFP expressing Scc9 cells closed wounds at a similar rate to Scc9 cells (Movie S3). Under these conditions, expression of Mtss1-GFP in SCC9 cells slightly enhances proliferation [25] , so the migration defect cannot be attributed to slower proliferation. Furthermore, Mtss1-GFP expression did not affect the ability of cells plated at low density to migrate but slightly increased the rate of spreading on a mixture of collagen I and IV ( Figure S2 ). Mtss1, thus, doesn't affect the motility of individual Scc9 cells but likely acts on cell-cell junction formation, strength and/or maintenance. Indeed, Mtss1-expressing SCC9 cells released fewer cells when mechanically disrupted in a dispase assay [26] than K4D mutant expressing or control cells ( Figure 1E ) suggesting increased junctional strength.
Mtss1 localizes to cell-cell contacts
Mtss1 is up-regulated at the early stages of hepatocellular and basal cell carcinomas where it drives proliferation but is lost during metastatic transition [12, 13, 14, 15, 16] . Metastatic conversion during EMT [1] involves loss of cell-cell contact inhibition, frequently driven by the loss or misregulation of E-cadherin [27, 28, 29] . As Mtss1 increased the strength of cell-cell junctions, we determined the effect of Mtss1 expression on E-cadherin cell-cell junction formation ( Figure 2 ). EGTA treatment of cells for 20 min led to a rapid departure of E-cadherin from cell-cell contact sites (0 min in Figure 2A ) but when calcium was added back, Mtss1 expressing showed accelerated junctional E-cadherin recruitment (Figure 2A -C). 60 min after Ca 2+ treatment, Mtss1 expressing cells showed more junctional E-cadherin than controls ( Figure 2C ). This agrees with Takaishi et al. [30] , who observed that stronger cell-cell junctions contain more E-cadherin. Mtss1 is rapidly recruited (after 5 min) during cell-cell junction formation (Movie S4 and Figure 2B ) and remains associated thoughout their formation in agreement with a recent report [17] . EGTA-induced cell-cell junction disassembly involves retraction followed by re-spreading of the cells. Mtss1 expression increases resistance to EGTA-induced disassembly of cell-cell junctions (data not shown) and Mtss1-GFP expressing Scc9 cells spread more readily on collagen ( Figure S2 ). To separate spreading from cell-cell junction formation we added Ca 2+ back to cells cultured overnight in Ca 2+ -free KSFM. Under these conditions, although there was variability within any given sample, overall we observed increased kinetics of de novo junction assembly in Mtss1-GFP expressing cells suggesting retraction/respreading effects were negligible ( Figure 2D ).
Mtss1 depletion reduces the recruitment of F-actin to cell-cell junctions
As Mtss1 expression accelerated cell-cell junction formation, we tested the effects of depleting Mtss1 with siRNA in confluent Scc9 cells with mature cell-cell contacts ( Figure 3 A and B) . Actin still appears to be recruited to junctions in Mtss1 depleted cells, but steady-state F-actin bundle structures were reduced at cell-cell contacts of Mtss1 depleted cells ( Figure 3A , arrows). Mtss1 is thus required for the maintenance of actin bundles at cell-cell junctions at steady-state. Mtss1 expression (or IRSp53, IRTKS expression) induces a dramatic F-actin accumulation at the rudimentary cellcell contacts made by fibroblastic cells [20, 21] that was not fully investigated in these previous studies. Neither DIMD nor K4D mutants of Mtss1 localized to or induced this phenotype, suggesting the IMD is critical for this activity [20, 21] .
Mtss1 depletion didn't reduce E-cadherin junctional localization ( Figure 3A ), suggesting that Mtss1 functions downstream of Ecadherin to regulate junctional F-actin. Depletion of Mtss1 in primary human keratinocytes did not affect the steady state maintenance of E-cadherin at cell-cell junctions (data not shown) and cells formed aggregates comparable to controls ( Figure 3C ). However, depletion of Mtss1 significantly increased disaggregation due to mechanical stress, suggesting that cell-cell junctions formed in the absence of Mtss1 are weaker ( Figure 3C -E). In support of our observations, MDCK cells depleted of calcium, lose Ecadherin staining from cell contact sites more slowly when they are overexpressing Mtss1 [17] , but the mechanism was not explored in this study, nor the effect of Mtss1 on the strength of cell-cell contacts.
Mtss1 drives enhanced Rac1 activation during cell-cell junction stabilization
Since Mtss1 activates Rac1 [20, 21, 22, 23] , and Rac1 is a major driver of actin assembly at cell-cell contacts [7, 31, 32, 33] we hypothesized that Mtss1 could regulate actin assembly at cell-cell contacts via Rac1. Indeed Mtss1 expression drove Rac1-GTP levels up by around 2.5-fold in confluent, but not subconfluent cultures ( Figure 4A ). This suggests that Mtss1 activation of Rac1 is dependent on cell-cell contacts and provides a potential mechanism for how Mtss1 drives F-actin formation to maintain strong Ecadherin contacts.
Mtss1 activation of Rac1 at cell-cell contacts could be driving more rapid and stable junction formation. We thus examined the activation of Rac1 during cell junction formation ( Figure 4B ). EGTA treatment did not significantly change the high level of Rac1 activation in confluent Mtss1 expressing cells ( Figure 4B , t = 0 minutes). Within 5 minutes after adding back calcium, Rac1-GTP transiently spiked in normal Scc9 cells, but rapidly decreased to approximately 2-fold over initial levels ( Figure 4B ). Rac1-GTP levels remained elevated in Mtss1-GFP expressing cells, during the initial 60 minutes of cell-cell junction formation, following which, both cell types had similar levels of Rac1-GTP.
We used the Raichu-Rac1 FRET probe tagged with a K-Ras membrane targeting sequence [34] to visualize active Rac1 during junction assembly. Raichu-Rac1 localized predominantly to the plasma membrane and internal puncta (presumably endocytic vesicles) in low Ca 2+ KSFM of control and Mtss1 expressing cells (Figure 4C, D) . After Ca 2+ addition, most Raichu-Rac1-positive cytoplasmic puncta disappeared from control but not Mtss1-expressing cells ( Figure 4E ). Further, Mtss1 expressing cells showed elevated Rac1-GTP on both intracellular puncta and at cell-cell junctions (Figure 4E -G; arrows in F), consistent with our biochemical analysis ( Figure 4A and B) . This shows for the first time the location of active Rac in response to Mtss1 expression.
A Rab5-Rac1-Tiam1 signaling circuit has been proposed to regulate spatial Rac1 activity for signaling in cell migration [35] . Mtss1 may therefore be regulating Rac1 activity via a similar recycling mechanism involving cell-cell adhesion-regulating RacGEFs, such as Tiam1 [6, 29, 35] . Rac1 activation recruits IQGAP-1 and F-actin to cell-cell junctions, which protects E-cadherin from constitutive endocytosis and promotes junction development [9, 10] . Therefore, Mtss1-driven Rac1-GTP activity may specifically stabilize E-cadherin in cell-cell contacts by increasing F-actin and thus reducing constitutive endocytosis.
In summary, we have shown that Mtss1 regulates the activity of Rac1 during cell-cell junction formation and that Mtss1 specifically localizes Rac1-GTP to these sites. Mtss1 increases both the development and strength of cell-cell contacts, which antagonizes cell dissociation from epithelial colonies and inhibits scattering. Finally we show that Mtss1 depletion results in disruption of the actin cytoskeleton at cell-cell junctions and increases the ability of cells to disaggregate. Critically our data provide a potential mechanistic explanation for the role of Mtss1 in regulation of the metastatic potential of cancer cells through enhancing cell-cell junction strength and blocking EMT.
Materials and Methods
Materials
Reagents were from Sigma-Aldrich (UK) unless otherwise stated. Mtss1 was cloned into the BamH1 and EcoR1 sites of pEGFP-N1 (Clontech) and mutated using standard molecular biology methods. Raichu-Rac1 (pRaichu 1011x) was obtained from M. Matsuda (Kyoto University, Japan). Dispase was from Gibco (Invitrogen).
Cell lines and culture
Scc9 cells were a kind gift of R. Daly (Garvan Institute, Sydney, Australia) and were maintained as described on the ATCC website. Stable Scc9 cells expressing Mtss1-GFP were selected in 0.5 mg/ml G418. For Ca 2+ chelation experiments, cells were incubated with 2 mM EGTA in Ca 2+ -free DMEM (Invitrogen) or were incubated overnight in KSFM-Ca 2+ free medium (Invitrogen). 2 mM CaCl 2 was added to induce junctions.
Scc9 cells were transfected using Polyfect (Qiagen) for DNA and Hyperfect (Qiagen) for siRNA using the manufacturer's protocol. Normal keratinocytes were transfected using Interferin (PeqLab) according to the manufacturer's protocol. Mtss1 siRNA was from Qiagen (Hs_Mtss1_5, target sequence, 59-CCGACGGATGTTC-CAAGCCAA-39) or Dharmacon (Mtss1 #3 59-CCAGUUGU-CUAACGGGUUU-39, Mtss1 #4 59-CAAGUGAACAGGU-GAUUCU-39). All stars-negative control or NT oligo controls were from Qiagen (1027280) and Dharmacon (D-00210-02).
For HGF-induced scattering, cells were seeded in 6-well plates at 0.5610 5 cells/well and cultured for 2-3 days. Cells were stimulated with 10 ng/ml HGF for 20 h.
The dispase assay was performed as described in [26] . Briefly, cells were grown to confluence over 3 days, washed with PBS and incubated with 2 mg/ml dispase/PBS (Gibco, Invitrogen) Monolayers were mechanically dissociated with a P1000 Gilson Pipetman followed by a 70 mm filter.
Normal keratinocytes were grown as described previously (Braga et al., 1997) . For aggregation assays, normal keratinocytes were trypsinised in 500 ml aggregation assay buffer (60% versene (v/v), 0.1% trypsin, 0.1 mM CaCl 2 ) to protect cadherin receptors from cleavage until single-cell suspension. Cells were counted and centrifuged at 900 rpm for 5 minutes. The cell pellet was resuspended in standard calcium medium (5610 4 cells/ml), set as hanging drops in a humid chamber (6 droplets per sample) and incubated for up to 120 minutes. Cells were pipetted gently to disaggregate clusters. Images were taken on an Olympus CKX41 microscope with a Colour View IIIu camera using cellˆD v. 2.4 software (Olympus). Areas of all aggregates following trituration were quantified using ImageJ and normalised to the initial aggregate in each droplet. Control values were arbitrarily set as 1 and Mtss1-depleted cell data expressed relative to controls.
FLIM-FRET analysis
Cells in KSFM-Ca 2+ free medium were transfected with Raichu-Rac1 and imaged the following day. Fluorescence resonance energy transfer (FRET) was detected using a Lambert Instruments fluorescence attachment (LIFA) on a Nikon Eclipse TE 2000-U microscope equipped with a 1006 oil immersion objective and a filter block consisting of a 436/206 excitation filter, a T455LP dichroic mirror, and a 480/40 M emission filter. We used a modulated 445 nm LED as light source, which, in combination with the modulated intensifier from the LIFA system. A FITC solution was used as a reference. Donor lifetime was analyzed using the Fluorescence Lifetime Imaging Microscopy (FLIM) software (version 1.2.7; Lambert Instruments, The Netherlands). For analysis, a 464 pixel box was used to measure the average lifetime from five different areas of the indicated regions, in a given cell. These measurements were used to calculate an average lifetime of that region in that cell.
Immunofluorescence
Cells were fixed in either 4% paraformaldehyde, followed by permeablisation in 0.1% Triton X-100 or for visualisation of Ecadherin junctions, fixed in 4% paraformaldehyde containing 0.1% Triton X-100 for 10 minutes which results in a greater extraction of Triton X-100 soluble proteins. Cells were labelled with mouse anti-E-cadherin (clone 36/E-Cadherin, BD Biosciences) diluted 1/500 and Alexa-350 phalloidin (Invitrogen). Images were acquired using an Olympus FV1000 confocal microscope and a 606 objective. Z-stacks were acquired at 0.5 mm intervals. Images were analyzed in ImageJ.
Rac activation assays and Western blotting
Rac-GTP pulldowns were performed as described [21] and [20] . 500 mg of cell lysates were incubated with 5 ml PAK-CRIB beads (approximately 20 mg) for 1 hour. Beads were then washed with lysis buffer, boiled and resolved on SDS-PAGE (4-12% gels; Invitrogen) before western blotting. Blots were probed with rabbit anti-Mtss1 [20] , and mouse anti-Rac (23A8, Upstate). Rac-GTP levels were quantified using imageJ and normalized to total Rac expression. Rac-GLISA was performed following the manufacturer's instructions (Cytoskelton Inc., USA).
Analysis of random cell motility and spreading 6-well plates were coated with a mixture of collage I and IV (at 10 mg/ml for 1 hour) and cells were seeded overnight. The number of phase dark cells was counted as a measure of cell spreading. For cell motility, cells were seeded overnight and then imaged using a Nikon TE2000 microscope. Images were acquired every 15 minutes for 24 hours. Random cell motility was measured using the manual tracking plug-in and data analyzed using the Ibidi chemotaxis and migration tool plug-in for ImageJ. 
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